Hicks, Jessica L.

Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer

Topper, M. J., Vaz, M., Chiappinelli, K. B., DeStefano Shields, C. E., Niknafs, N., Yen, R.-W. C., Wenzel, A., Hicks, J., Ballew, M., Stone, M., et al. (2017) · Cell

Cancer Immunotherapy and BiomarkersEpigenetics and DNA Methylation

Cited by 537

Telomere Shortening Is Nearly Universal in Pancreatic Intraepithelial Neoplasia

van Heek, N. T., Meeker, A. K., Kern, S. E., Yeo, C. J., Lillemoe, K. D., Cameron, J. L., Offerhaus, G. J. A., Hicks, J. L., Wilentz, R. E., Goggins, M. G., et al. (2002) · The American Journal of Pathology

Telomeres, Telomerase, and SenescencePancreatic and Hepatic Oncology Research

Cited by 363

Telomere Length Abnormalities Occur Early in the Initiation of Epithelial Carcinogenesis

Meeker, A. K., Hicks, J. L., Iacobuzio-Donahue, C. A., Montgomery, E. A., Westra, W. H., Chan, T. Y., Ronnett, B. M., & De Marzo, A. M. (2004) · Clinical Cancer Research

Telomeres, Telomerase, and SenescenceCancer-related Molecular Pathways

Cited by 306

Telomere Length Assessment in Human Archival Tissues

Meeker, A. K., Gage, W. R., Hicks, J. L., Simon, I., Coffman, J. R., Platz, E. A., March, G. E., & De Marzo, A. M. (2002) · The American Journal of Pathology

Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model Organisms

Cited by 209

A prospective investigation of PTEN loss and ERG expression in lethal prostate cancer

Ahearn, T. U., Pettersson, A., Ebot, E. M., Gerke, T., Graff, R. E., Morais, C. L., Hicks, J. L., Wilson, K. M., Rider, J. R., Sesso, H. D., et al. (2015) · Journal of the National Cancer Institute

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment

Cited by 186

Telomere Shortening Occurs in Subsets of Normal Breast Epithelium as well as in Situ and Invasive Carcinoma

Meeker, A. K., Hicks, J. L., Gabrielson, E., Strauss, W. M., De Marzo, A. M., & Argani, P. (2004) · The American Journal of Pathology

Telomeres, Telomerase, and SenescenceBreast Lesions and Carcinomas

Cited by 140

USP22 regulates oncogenic signaling pathways to drive lethal cancer progression

Schrecengost, R. S., Dean, J. L., Goodwin, J. F., Schiewer, M. J., Urban, M. W., Stanek, T. J., Sussman, R. T., Hicks, J. L., Birbe, R. C., Draganova-Tacheva, R. A., et al. (2014) · Cancer Research

Ubiquitin and proteasome pathwaysProstate Cancer Treatment and Research

Cited by 126